170 related articles for article (PubMed ID: 5739611)
1. [Clinical considerations on the therapeutic action of Nucleodoxine].
Idéo G
Omnia Med Ther; 1968; 46(2):409-15. PubMed ID: 5739611
[No Abstract] [Full Text] [Related]
2. [Therapeutic activity of a combined taurine-nucleotide-vitamin product in some states of hepatic disease].
Piazza V
Omnia Med Ther; 1966; 4(2):521-8. PubMed ID: 5962154
[No Abstract] [Full Text] [Related]
3. [Nucleodoxin in the treatment of alcoholic myocardiopathies. Hemodynamic evaluations with the polygraphic method].
Forattini C
Omnia Med Ther; 1970; 48(3):361-73. PubMed ID: 5513564
[No Abstract] [Full Text] [Related]
4. [Therapeutic effect of a combination product (taurine-nucleotides-vitamins) in the course of detoxication of psychiatric alcoholic patients].
Dogliani P; Senini G; Bertuzzi F; Gherardi S
Omnia Med Ther; 1970; 48(1):165-74. PubMed ID: 5488123
[No Abstract] [Full Text] [Related]
5. [Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
De Lorenzi F
Clin Ter; 1971 Jun; 57(5):441-70. PubMed ID: 5113575
[No Abstract] [Full Text] [Related]
6. [Use in geriatrics of an association of taurine, nucleotides and vitamins].
Calabrese L; Montagnani I
Clin Ter; 1970 Mar; 52(5):451-9. PubMed ID: 5421986
[No Abstract] [Full Text] [Related]
7. [Influence of taurine-nucleotide-vitamin compound on experimental hypercholesteremia and on some forms of human arteriosclerosis].
Piazza V
Omnia Med Ther; 1966; 4(2):513-20. PubMed ID: 5962153
[No Abstract] [Full Text] [Related]
8. [Therapeutic activity, evaluated by hepatoparenchymal clearence with indocyanine green, of a "taurine-nucleotide-vitamin" drug association in hepatic steatosis].
Proto C; Grasso G; Levi GF
Omnia Med Ther; 1967; 45(4):857-63. PubMed ID: 5605420
[No Abstract] [Full Text] [Related]
9. [Research on the value of a taurine, nucleotide and vitamin combination in neurologic diseases].
Brogi L; Avesani A
Clin Ter; 1974 Aug; 70(4):357-78. PubMed ID: 4426172
[No Abstract] [Full Text] [Related]
10. [Therapeutic use in the neurological field of a new pharmaceutical compound: monophosphate nucleotide (AMP and UMP) with taurine, pyridoxine and cyanocobalamine].
Bergamini L
Hospital (Rio J); 1967 May; 71(5):1459-73. PubMed ID: 5303476
[No Abstract] [Full Text] [Related]
11. [A new hepatoprotective preparation. Biochemical aspects and clinical studies].
Boselli A
Clin Ter; 1968 Jan; 44(2):115-56. PubMed ID: 4244601
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of a new preparation with liver-protective and anti-anemic action].
Cairella M
Clin Ter; 1966 Dec; 39(6):567-76. PubMed ID: 4232883
[No Abstract] [Full Text] [Related]
13. [The problem of dishabituation in chronic alcoholic intoxication. Studies and observations using a preparation with nucleotides and taurine base (nucleodoxine)].
Franchini C; Ferutta AM; Colonna F; Ferutta M; Coro S
Omnia Med Ther; 1969; 47(1):221-31. PubMed ID: 5365636
[No Abstract] [Full Text] [Related]
14. [Drug therapy of chronic inflammatory liver diseases].
Vetter K; Kettler LH; Kaschube I; Lüder W
Dtsch Z Verdau Stoffwechselkr; 1966 Dec; 26(3):121-9. PubMed ID: 5998373
[No Abstract] [Full Text] [Related]
15. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
Verzetti G; Emanuelli G; Montagnani M
Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
[No Abstract] [Full Text] [Related]
16. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
Wildhirt E
Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
[No Abstract] [Full Text] [Related]
17. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
Heinrich HC
Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
[No Abstract] [Full Text] [Related]
18. [Use of a combination of flufenamic acid and vitamins in rheumatology].
Lanzarini AM; Speranza M
Clin Ter; 1970 Mar; 52(6):547-56. PubMed ID: 5452998
[No Abstract] [Full Text] [Related]
19. [Clinical considerations on the use of a new preparation with hepatoprotective action].
Di Lorenzo S
Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
[No Abstract] [Full Text] [Related]
20. [Effects of parenteral administration of hepatotropic preparation with dynamotropic properties in patients with liver diseases].
Rottini E; Scianaro L
Clin Ter; 1969 Oct; 51(1):49-61. PubMed ID: 5364033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
